Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
McCreadie, Robin G.
Wiles, David H.
Grant, Stewart M.
Moore, John W.
Crocket, George T.
Mahmood, Zahid
Livingston, Martin G.
Watt, James A. G.
Greene, J. G.
Kershaw, Peter W.
Todd, Norman A.
Scott, Angus M.
Loudon, John
Dyer, James A. T.
Philip, Alistair E.
and
Batchelor, David
1988.
The Scottish First Episode Schizophrenia Study V. One-year Follow-up.
British Journal of Psychiatry,
Vol. 152,
Issue. 4,
p.
470.
McCreadie, R. G.
Wiles, D.
Grant, S.
Crockett, G. T.
Mahmood, Z.
Livingston, M. G.
Watt, J. A. G.
Greene, J. G.
Kershaw, P. W.
Todd, N. A.
Scott, A. M.
Loudon, J.
Dyer, J. A. T.
Philip, A. E.
and
Batchelor, D.
1989.
The Scottish first episode schizophrenia study.
Acta Psychiatrica Scandinavica,
Vol. 80,
Issue. 6,
p.
597.
McCreadie, Robin G.
Wiles, David H.
Livingston, Martin G.
Watt, James A. G.
Greene, J. G.
Kershaw, Peter W.
Todd, Norman A.
Scott, Angus M.
Crocket, George T.
Mahmood, Zahid
Loudon, John
Dyer, James A. T.
Philip, Alistair E.
and
Batchelor, David
1992.
The Scottish First Episode Schizophrenia Study.
British Journal of Psychiatry,
Vol. 161,
Issue. 4,
p.
496.
Waring, Em
1995.
The Psychobiology of First-Episode Schizophrenia.
The Canadian Journal of Psychiatry,
Vol. 40,
Issue. 7_suppl,
p.
33.
Ronchi, Diana De
Ruggeri, Mirella
Belelli, Gabriella
and
Volterra, Vittorio
1996.
Levosulpiride versus pimozide in negative symptoms of schizophrenia.
Current Therapeutic Research,
Vol. 57,
Issue. 10,
p.
797.
Gartenmaier, A.
Gaese, F.
and
Soyka, M.
1998.
Flupentixol — Typisches oder atypisches Wirkspektrum?.
p.
35.
Remington, Gary
Kapur, Shitij
and
Zipursky, Robert B.
1998.
Pharmacotherapy of first-episode schizophrenia.
British Journal of Psychiatry,
Vol. 172,
Issue. S33,
p.
66.
Robinson, Delbert G.
Woerner, Margaret G.
Alvir, Jose Ma.J.
Geisler, Stephen
Koreen, Amy
Sheitman, Brian
Chakos, Miranda
Mayerhoff, David
Bilder, Robert
Goldman, Robert
and
Lieberman, Jeffrey A.
1999.
Predictors of Treatment Response From a First Episode of Schizophrenia or Schizoaffective Disorder.
American Journal of Psychiatry,
Vol. 156,
Issue. 4,
p.
544.
Sultana, A
McMonagle, T
and
Sultana, Alec
2000.
Cochrane Database of Systematic Reviews.
Kang, Jiesheng
Chen, Xiao-Liang
and
Rampe, David
2001.
The Antipsychotic Drugs Sertindole and Pimozide Block erg3, a Human Brain K+ Channel.
Biochemical and Biophysical Research Communications,
Vol. 286,
Issue. 3,
p.
499.
M??ller, M.J.
Wetzel, H.
and
Benkert, O.
2002.
Differential effects of high-dose amisulpride versus flupentixol on latent dimensions of depressive and negative symptomatology in acute schizophrenia: an evaluation using confirmatory factor analysis.
International Clinical Psychopharmacology,
Vol. 17,
Issue. 5,
p.
249.
Valenstein, Marcia
Copeland, Laurel A.
Blow, Frederic C.
McCarthy, John F.
Zeber, John E.
Gillon, Leah
Bingham, C. Raymond
and
Stavenger, Thomas
2002.
Pharmacy Data Identify Poorly Adherent Patients With Schizophrenia at Increased Risk for Admission.
Medical Care,
Vol. 40,
Issue. 8,
p.
630.
Marshall, M
Lockwood, A
and
Marshall, Max
2003.
The Cochrane Database of Systematic Reviews (Protocol).
Bradford, Daniel W
Perkins, Diana O
and
Lieberman, Jeffrey A
2003.
Pharmacological Management of First-Episode Schizophrenia and Related Nonaffective Psychoses.
Drugs,
Vol. 63,
Issue. 21,
p.
2265.
Lorenzo, Cynthia R
and
Koo, John
2004.
Pimozide in Dermatologic Practice.
American Journal of Clinical Dermatology,
Vol. 5,
Issue. 5,
p.
339.
Edwards, Natalie Christine
Locklear, Julie C.
Rupnow, Marcia F. T.
and
Diamond, Ronald J.
2005.
Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA.
PharmacoEconomics,
Vol. 23,
Issue. S1,
p.
75.
Falkai, Peter
Wobrock, Thomas
Lieberman, Jeffrey
Glenthoj, Birte
Gattaz, Wagner F.
Möller, Hans-Jürgen
WFSBP Task Force on Treatment Guide
Falkai, Peter
Wobrock, Thomas
Lieberman, Jeffrey
Glenthoj, Birte
Gattaz, Wagner F.
Möller, Hans-Jürgen
and
WFSBP Task Force on Treatment Guide
2005.
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Acute treatment of schizophrenia.
The World Journal of Biological Psychiatry,
Vol. 6,
Issue. 3,
p.
132.
Witzel, Joachim -G.
2006.
Polypharmazie in der Behandlung psychischer Erkrankungen.
p.
215.
Marshall, Max
Rathbone, John
and
Marshall, Max
2006.
Cochrane Database of Systematic Reviews.
Ravasio, Roberto
and
Ferrannini, L.
2006.
Costo-efficacia di risperidone iniettabile a rilascio prolungato nel trattamento della schizofrenia in Italia.
PharmacoEconomics Italian Research Articles,
Vol. 8,
Issue. 1,
p.
19.
eLetters
No eLetters have been published for this article.